BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16868721)

  • 1. Matrix metalloproteinase and cytokine production by bone marrow adherent cells from multiple myeloma patients.
    Zdzisińska B; Walter-Croneck A; Dmoszyńska A; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2006; 54(4):289-96. PubMed ID: 16868721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases-1 and -2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients.
    Zdzisińska B; Walter-Croneck A; Kandefer-Szerszeń M
    Leuk Res; 2008 Nov; 32(11):1763-9. PubMed ID: 18472160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble IL-6R alpha upregulated IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells.
    Barillé S; Collette M; Thabard W; Bleunven C; Bataille R; Amiot M
    Cytokine; 2000 Sep; 12(9):1426-9. PubMed ID: 10976008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation.
    Barillé S; Bataille R; Rapp MJ; Harousseau JL; Amiot M
    J Immunol; 1999 Nov; 163(10):5723-8. PubMed ID: 10553104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
    Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
    Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of anti-myeloma activity of interleukin-2 activated bone marrow in vitro].
    Liu W; Chen SL; Liu JW; Li X; Xia CQ; Qi M
    Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):205-8. PubMed ID: 15949260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK.
    Hecht M; Heider U; Kaiser M; von Metzler I; Sterz J; Sezer O
    Br J Haematol; 2007 Aug; 138(4):446-58. PubMed ID: 17593251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
    Braundmeier AG; Nowak RA
    Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment.
    Derenne S; Amiot M; Barillé S; Collette M; Robillard N; Berthaud P; Harousseau JL; Bataille R
    J Bone Miner Res; 1999 Dec; 14(12):2048-56. PubMed ID: 10620064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase inhibitor reduces apoptosis induction of bone marrow cells in MDS-RA.
    Arimura K; Arima N; Matsushita K; Ohtsubo H; Fujiwara H; Kukita T; Ozaki A; Hagiwara T; Hamada H; Yoshino K; Tei C
    Eur J Haematol; 2004 Jul; 73(1):17-24. PubMed ID: 15182333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
    Anand SP; Selvaraj P
    Clin Immunol; 2009 Oct; 133(1):126-31. PubMed ID: 19615945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.
    Alexandrakis MG; Sfiridaki A; Miyakis S; Pappa C; Kandidaki E; Alegakis A; Margioris AN
    Clin Chim Acta; 2007 Apr; 379(1-2):31-5. PubMed ID: 17234170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone.
    Hulejová H; Baresová V; Klézl Z; Polanská M; Adam M; Senolt L
    Cytokine; 2007 Jun; 38(3):151-6. PubMed ID: 17689092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Production of interleukin-1 and interleukin-6 in a culture of mononuclear cells of peripheral blood and bone marrow in multiple myeloma].
    Kliushnenkova EN; Lutskaia TD; Golenkov AK; Malaĭtsev VV
    Biull Eksp Biol Med; 1993 May; 115(5):507-10. PubMed ID: 8043836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanisms of pathogenesis in Lyme arthritis before and after antibiotic treatment.
    Lin B; Kidder JM; Noring R; Steere AC; Klempner MS; Hu LT
    J Infect Dis; 2001 Jul; 184(2):174-80. PubMed ID: 11424014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells.
    Barillé S; Akhoundi C; Collette M; Mellerin MP; Rapp MJ; Harousseau JL; Bataille R; Amiot M
    Blood; 1997 Aug; 90(4):1649-55. PubMed ID: 9269785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of interleukin 1 beta, a potent bone resorbing cytokine, by cultured human myeloma cells.
    Yamamoto I; Kawano M; Sone T; Iwato K; Tanaka H; Ishikawa H; Kitamura N; Lee K; Shigeno C; Konishi J
    Cancer Res; 1989 Aug; 49(15):4242-6. PubMed ID: 2787204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production.
    Zachou K; Rigopoulou EI; Tsikrikoni A; Alexandrakis MG; Passam F; Kyriakou DS; Stathakis NE; Dalekos GN
    J Autoimmun; 2005 Dec; 25(4):283-8. PubMed ID: 16242912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.